Inventor

Renata Pasqualini

Inventor

Houston, TX, US

Overview

1997–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes29%

C07KPeptides20%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

G01NInvestigating or analysing materials by determining their chemical or physical properties10%

C12NMicroorganisms or enzymes9%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%

B82YSpecific uses or applications of nanostructures3%

C12MApparatus for enzymology or microbiology3%

A01NPreservation of bodies of humans or animals or plants or parts thereof2%

PatentTitleYear

10,844,365Systems and methods for magnetic guidance and patterning of materials2020 9,909,116'Systems and methods for magnetic guidance and patterning of materials'2018 9,827,327Methods and compositions related to adenoassociated virus-phage particles2017 9,592,238'Anti-ceramide monoclonal antibody 2A2'2017 8,846,859'Compositions and methods of use of targeting peptides against placenta and adipose tissues'2014 8,815,231'Systems and methods for magnetic guidance and patterning of materials'2014 8,710,017'Human and mouse targeting peptides identified by phage display'2014 8,562,993'Methods for treating GI syndrome and graft versus host disease'2013 8,507,445'Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer'2013 8,470,528'Methods and compositions related to adenoassociated virus-phage particles'2013 8,450,278'MUC18 targeting peptides'2013 8,252,764'Compositions and methods of use of targeting peptides against placenta and adipose tissues'2012 8,067,377'Peptide compositions for targeting adipose tissue'2011 7,951,362'Compositions and methods of use of targeting peptides against placenta and adipose tissues'2011 7,914,780'Aminopeptidase A (APA) targeting peptides for the treatment of cancer'2011 7,781,565'Compositions and methods related to profiling a plurality of cells based on peptide binding'2010 7,671,010'Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer'2010 7,452,964'Compositions and methods of use of targeting peptides against placenta and adipose tissues'2008 7,420,030'Aminopeptidase A (APA) targeting peptides for the treatment of cancer'2008 7,341,710'Method of identifying molecules that home to a selected organ in vivo'2008 7,018,615'Method of identifying molecules that home to a selected organ in vivo'2006 6,933,281'Molecules that home to various selected organs or tissues'2005 6,784,153'Methods of homing molecules to lung using membrane dipeptidase'2004 6,743,892'Molecules that home to a selected organ in vivo'2004 6,610,651'Molecules that home to various selected organs or tissues'2003 6,576,239'Angiogenic homing molecules and conjugates derived therefrom'2003 6,528,481'NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods'2003 6,491,894'NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same'2002 6,475,488'Methods of inhibiting angiogenesis and ameliorating cancer by using superfibronectin'2002 6,306,365'Method of identifying molecules that home to a selected organ in vivo'2001 6,296,832'Molecules that home to a selected organ in vivo'2001 6,232,287'Molecules that home to various selected organs or tissues'2001 6,180,084'NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same'2001 6,174,687'Methods of identifying lung homing molecules using membrane dipeptidase'2001 6,068,829'Method of identifying molecules that home to a selected organ in vivo'2000 5,955,572'Structural mimics of RGD-binding sites'1999 5,922,676'Methods of inhibiting cancer by using superfibronectin'1999 5,817,750'Structural mimics of RGD-binding sites'1998 5,622,699'Method of identifying molecules that home to a selected organ in vivo'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2004Patents assigned to JOLLA CANCER RES FOUND (4)· patent assignee history

1997–2008Based in Solana Beach, CA, US· patent location history

1999–2008Patents assigned to BURNHAM INST (15)· patent assignee history

2006–2020Based in Houston, TX, US· patent location history

2008–2020Patents assigned to UNIV TEXAS (18)· patent assignee history

2011–2017Patents assigned to ARAP WADIH (11)· patent assignee history

2011–2017Patents assigned to PASQUALINI RENATA (11)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV TEXAS	18	2008–2020
BURNHAM INST	15	1999–2008
ARAP WADIH	11	2011–2017
PASQUALINI RENATAself	11	2011–2017
JOLLA CANCER RES FOUND	4	1997–2004

Locations

Location	Patents	Span
Houston, Texas, US	20	2006–2020
Solana Beach, California, US	19	1997–2008